Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Neurocrine Biosciences Inc (NBIX) vs Open Text Corporation (OTEX) Price & Performance

Neurocrine Biosciences IncTrade
Open Text CorporationTrade

Price performance (Past 24H)

Key statistics

Neurocrine Biosciences Inc vs Open Text Corporation — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Open Text Corporation trades at $22.77 (market cap $5.61B). The key difference: Neurocrine Biosciences Inc is far larger — about 3.1× Open Text Corporation's market cap, and Open Text Corporation pays a 4.72% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.

NBIXOTEX
Market Cap
$17.40B$5.61B
Sector
HealthTechnology
52-Week High
$180.55$39.69
52-Week Low
$123.10$20.01
Enterprise Value
$16.49B$10.77B
Dividend Yield
4.72%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX

About Open Text Corporation

Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.

Read more on OTEX